Keyword: drugmaker

News

Valeant Names New Finance Chief

25.08.2016 - Canada-domiciled US drugmaker Valeant has appointed Paul Herendeen, former chief financial officer of Zoetis, to replace its own CFO, Robert Rosiello, as the company struggles to...

News

Simone Menne Named CFO of Boehringer Ingelheim

16.06.2016 - Simone Menne has been appointed chief financial officer (CFO) of German drugmaker Boehringer Ingelheim with effect from Sept. 1, 2016. She will succeed Hubertus von Baumbach, who...

News

Sanofi Moves to Replace Medivation's Board

15.06.2016 - French drugmaker Sanofi today said it has filed definitive consent solicitation materials with the US Securities and Exchange Commission (SEC) seeking to remove and replace the...

News

Sanofi Takes Case for Medivation to the SEC

09.06.2016 - French drugmaker Sanofi, which is pursuing a takeover of US biopharmaceuticals producer Medivation, has filed an investor presentation with the US Securities and Exchange...

News

AstraZeneca Initiates Broad Genomics Project

28.04.2016 - As part of a newly announced collaboration with non-profit scientific institutes and high-tech companies, British-Swedish drugmaker AstraZeneca and its global biologics research...

News

Ackman Trims Valeant Stake to Create Tax Benefits

04.01.2016 - Pershing Square Capital Management, the hedge fund of billionaire US activist investor Bill Ackman, has trimmed its stake in Canada-headquartered Valeant Pharmaceuticals from...

News

Sanofi Launches new Long-term Strategy

12.11.2015 - French drugmaker Sanofi has announced a new long-term strategy focused on four pillars including a reshaping of its portfolio, new drug launches, innovation in R&D and a...

News

Court Says Mylan Can Uphold Perrigo Bid

10.11.2015 - A federal district court judge in New York has ruled that Mylan can continue its hostile takeover bid for Perrigo. In the case heard by the court, Perrigo claimed Mylan had made...